DOCSLIB.ORG

NLRC5/MHC Class I Transactivator Is a Target for Immune Evasion in Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NLRC5/MHC Class I Transactivator Is a Target for Immune Evasion in Cancer NLRC5/MHC class I transactivator is a target for immune evasion in cancer Sayuri Yoshihamaa,b, Jason Roszikc, Isaac Downsa, Torsten B. Meissnerd, Saptha Vijayana, Bjoern Chapuye, Tabasum Sidiqa, Margaret A. Shippe, Gregory A. Lizeec,f, and Koichi S. Kobayashia,1 aDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843; bDepartment of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan; cDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; dDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115; eDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; and fDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054 Edited by Jeremy Boss, Emory University School of Medicine, Atlanta, GA, and accepted by the Editorial Board April 11, 2016 (received for review February 5, 2016) Cancer cells develop under immune surveillance, thus necessitating but also activates other critical genes involved in the MHC class I immune escape for successful growth. Loss of MHC class I expression antigen-presentation pathway, including the immunoproteasome provides a key immune evasion strategy in many cancers, although component LMP2 (PSMB9), peptide transporter TAP1,andB2M the molecular mechanisms remain elusive. MHC class I transactivator (14, 17), thus regulating most of the key components in the MHC (CITA), known as “NLRC5” [NOD-like receptor (NLR) family, caspase class I antigen-presentation machinery. Nlrc5-deficient mice ex- recruitment (CARD) domain containing 5], has recently been identified hibit impaired constitutive and inducible expression of MHC as a critical transcriptional coactivator of MHC class I gene expression. class I genes in vivo (18–22). In addition, Nlrc5-deficient cells + Here we show that the MHC class I transactivation pathway mediated display an impaired ability to elicit CD8 T-cell activation, as by CITA/NLRC5 constitutes a target for cancer immune evasion. In all evidenced by impaired IFN-γ production and diminished cyto- the 21 tumor types we examined, NLRC5 expression was highly cor- lytic activity (18, 19, 21). related with the expression of MHC class I, with cytotoxic T-cell markers, and with genes in the MHC class I antigen-presentation Results pathway, including LMP2/LMP7, TAP1,andβ2-microglobulin. Epige- Expression of NLRC5 and MHC Class I Genes Is Correlated in Human netic and genetic alterations in cancers, including promoter methyl- Cancers. Because of the prominent role of NLRC5 in orches- ation, copy number loss, and somatic mutations, were most prevalent trating the expression of MHC class I and class I-related genes, we in NLRC5 among all MHC class I-related genes and were associated examined gene-expression profiles of biopsy samples from the co- with the impaired expression of components of the MHC class I path- hort of 7,747 solid cancer patients in The Cancer Genome Atlas way. Strikingly, NLRC5 expression was significantly associated with (TCGA) database. The expression of HLA-B was highly correlated + NLRC5 = the activation of CD8 cytotoxic T cells and patient survival in multiple with the level of expression in the entire cohort (rs 0.753) A cancer types. Thus, NLRC5 constitutes a novel prognostic biomarker (Fig. 1 ). Correlation analysis for gene expression among 14 cancer HLA-B NLRC5 and potential therapeutic target of cancers. types demonstrated that and expression showed high positive correlation (rs > 0.70) in nine cancer types and in- > MHC class I | CITA | cancer | immune evasion | NLRC5 termediate positive correlation (rs 0.50) in five cancer types (Fig. 1 B and C), with the highest correlation observed in melanoma. In addition to HLA-B, the expression of HLA-A, HLA-C, B2M, LMP2, uring cancer progression, neoplastic cells accumulate nu- LMP7 (PSMB8), and TAP1 was also highly correlated with NLRC5 Dmerous mutations that constitute potentially immunogenic expression in melanoma and other cancers (Fig. 1D and Fig. S1A). neo-epitopes. Thus, most tumors concurrently need to use mechanisms that enable escape from immune surveillance for Significance successful growth and progression (1). It has been demonstrated that cancer cells use multiple strategies of immune evasion, in- + Tumor antigen presentation to CD8 T cells by MHC class I cluding increased resistance to cytotoxic T-cell killing, induction of molecules is crucial for immune responses against cancers, anergy in activated T cells, elimination of effector T cells, recruit- whereas the loss of MHC class I is a common immune evasion ment of regulatory immune cell subsets, and reduced recognition of strategy used by cancers. However, the molecular mechanisms tumor-associated antigens by effector T cells (2). Impaired MHC leading to MHC class I deficiency have remained poorly de- class I-mediated antigen presentation is a major immune evasion fined. We demonstrate here that MHC class I transactivator mechanism in cancer (3, 4), with MHC class I loss reported in (CITA)/NOD-like receptor (NLR) family, caspase recruitment cervical cancer (92%) (5), penile cancer (80%) (6), breast cancer (CARD) domain containing 5 (NLRC5) is a major target for (71%) (7), nonsmall cell lung cancer (64%) (8), and esophageal cancer immune evasion. Reduced expression of MHC class I squamous cell carcinoma (67%) (9), among others. Although a and related genes in cancer is frequently associated with genetic number of mechanisms have been described for HLA loss, includ- and epigenetic changes in NLRC5. The reduced NLRC5 expression ing the loss of heterozygosity, HLA gene methylation, nonsense/ + TAP1/2 β B2M islinkedtoimpairedCD8 T-cell activation and poor patient missense mutations, and loss of or 2-microglobulin ( ), prognosis. These data indicate that CITA/NLRC5 is a novel prog- the dominant underlying molecular mechanism seems to reside at nostic marker and potential therapeutic target of cancers. the transcriptional level (10). Transcriptional regulation of MHC class I genes remained largely undefined until the recent discovery Author contributions: S.Y., T.B.M., S.V., B.C., M.A.S., and K.S.K. designed research; S.Y., I.D., of CITA (MHC class I transactivator), known as NLRC5 [NOD- T.B.M., S.V., B.C., and T.S. performed research; S.Y., J.R., I.D., T.B.M., S.V., B.C., M.A.S., G.A.L., and like receptor (NLR) family, caspase recruitment (CARD) domain K.S.K. analyzed data; and S.Y., G.A.L., and K.S.K. wrote the paper. containing 5] (11, 12). NLRC5 is an IFN-γ–inducible nuclear pro- The authors declare no conflict of interest. tein (13–15) that specifically associates with and activates promoters This article is a PNAS Direct Submission. J.B. is a guest editor invited by the Editorial Board. of MHC class I genes by generating a CITA enhanceosome com- 1To whom correspondence should be addressed. Email: [email protected]. plex with other transcription factors (14, 16, 17). A striking feature This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. INFLAMMATION IMMUNOLOGY AND of CITA/NLRC5 is that it does not solely induce MHC class I genes 1073/pnas.1602069113/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1602069113 PNAS | May 24, 2016 | vol. 113 | no. 21 | 5999–6004 Downloaded by guest on October 2, 2021 Preferential Methylation of NLRC5 in Cancer Is Associated with AB5 1 r ) =0.753 (p<0.001) r Impaired Cytotoxic T-Lymphocyte Activity. 0.8 Epigenetic changes in 4 0.6 0.4 cancer cells represent an important mechanism to alter gene 3 0.2 expression in favor of cancer growth and immune evasion (26). 0 (log10, TPM) 2 HLA-B expression n=7747 Abnormal methylation of CpG islands in promoter regions can 1 -2 -1 0 1 2 3 transcriptionally suppress genes that are unfavorable for cancer NLRC5 expression expression of NLRC5 x HLA-B (log10, TPM) growth (27). Treatment of various cancer cell lines with a DNA- C Melanoma Bladder Thyroid Breast Uterine Brain 5 methylation inhibitor, 5-azacitidine (5-Aza), resulted in the up- 5 r =0.849 (p<0.001) 5 r =0.848 (p<0.001) 5 r =0.839 (p<0.001) 5 r =0.800 (p<0.001) r =0.763 (p<0.001) 5 r =0.745 (p<0.001) 4 NLRC5 HLA-B 4 4 regulation of and expression, suggesting that 4 4 4 3 3 3 methylation of the NLRC5 promoter might play a role in the loss 3 3 3 2 2 2 (log10, TPM) of MHC class I expression in cancer (Fig. 2A). Therefore, the HLA-B expression 1 1 2 2 1 2 -1 0 1 2 -10123-1 0 1 2 -1 0 1 2 3 -10123 -1012 NLRC5 NLRC5 expression (log10, TPM) level of DNA methylation at a CpG island in the pro- Melanoma (n=471) moter in various cancer types was quantified using a methylation- D HLA-A HLA-C B2M LMP2 LMP7 TAP1 r =0.693 (p<0.001) r =0.805 (p<0.001) r =0.797 (p<0.001) r =0.885 (p<0.001) r =0.825 (p<0.001) 4 r =0.857 (p<0.001) 5 5 5 3 3 specific probe (Fig. 2B). Methylation of the NLRC5 promoter 4 2 3 4 4 2 was observed at higher frequency in multiple cancers than in the 3 1 2 3 3 1 corresponding normal tissues (excluding prostate, thyroid, and 2 0 1 ( log10, TPM) ( log10, Gene expression kidney, where high methylation was observed even in normal 2 1 2 -1 0 0 -1012-1012-1012-1012-1012-1012 NLRC5 expression (log10, TPM) tissues) (Fig. 2C and Fig. S2A). Furthermore, analysis of biopsy normal tumor samples from 6,523 solid cancer patients revealed that methyl- E 3 r =0.638 (p<0.001) F 3 r =0.580 (p<0.001) G 2 2 n=106 NLRC5 Prostate n=498 ** ation of the promoter was negatively correlated with 1 1 n=320 NLRC5 = − D 0 0 Lung n=1019 ** expression (rs 0.585) (Fig.
Load more

Recommended publications
  • The Expression of NOD2, NLRP3 and NLRC5 and Renal Injury in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Wang et al. J Transl Med (2019) 17:197 https://doi.org/10.1186/s12967-019-1949-5 Journal of Translational Medicine RESEARCH Open Access The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis Luo‑Yi Wang1,2,3, Xiao‑Jing Sun1,2,3, Min Chen1,2,3* and Ming‑Hui Zhao1,2,3,4 Abstract Background: Nucleotide‑binding oligomerization domain (NOD)‑like receptors (NLRs) are intracellular sensors of pathogens and molecules from damaged cells to regulate the infammatory response in the innate immune system. Emerging evidences suggested a potential role of NLRs in anti‑neutrophil cytoplasmic antibody (ANCA)‑associated vasculitis (AAV). This study aimed to investigate the expression of nucleotide‑binding oligomerization domain con‑ taining protein 2 (NOD2), NOD‑like receptor family pyrin domain containing 3 (NLRP3) and NOD‑like receptor family CARD domain containing 5 (NLRC5) in kidneys of AAV patients, and further explored their associations with clinical and pathological parameters. Methods: Thirty‑four AAV patients in active stage were recruited. Their renal specimens were processed with immu‑ nohistochemistry to assess the expression of three NLRs, and with double immunofuorescence to detect NLRs on intrinsic and infltrating cells. Analysis of gene expression was also adopted in cultured human podocytes. The associa‑ tions between expression of NLRs and clinicopathological parameters were analyzed. Results: The expression of NOD2, NLRP3 and NLRC5 was signifcantly higher in kidneys from AAV patients than those from normal controls, minimal change disease or class IV lupus nephritis. These NLRs co‑localized with podocytes and infltrating infammatory cells.
    [Show full text]
  • Cytotoxic T Cells Class I- Dependent Lymphocyte Killing by NLRC5 Deficiency Selectively Impairs
    The Journal of Immunology NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells Francesco Staehli,* Kristina Ludigs,* Leonhard X. Heinz,† Queralt Seguı´n-Este´vez,‡ Isabel Ferrero,x Marion Braun,x Kate Schroder,{ Manuele Rebsamen,† Aubry Tardivel,* Chantal Mattmann,* H. Robson MacDonald,x Pedro Romero,x Walter Reith,‡ Greta Guarda,*,1 and Ju¨rg Tschopp*,1,2 Nucleotide-binding oligomerization domain-like receptors (NLRs) are intracellular proteins involved in innate-driven inflamma- tory responses. The function of the family member NLR caspase recruitment domain containing protein 5 (NLRC5) remains a matter of debate, particularly with respect to NF-kB activation, type I IFN, and MHC I expression. To address the role of NLRC5, we generated Nlrc5-deficient mice (Nlrc5D/D). In this article we show that these animals exhibit slightly decreased CD8+ T cell percentages, a phenotype compatible with deregulated MHC I expression. Of interest, NLRC5 ablation only mildly affected MHC I expression on APCs and, accordingly, Nlrc5D/D macrophages efficiently primed CD8+ T cells. In contrast, NLRC5 deficiency dramatically impaired basal expression of MHC I in T, NKT, and NK lymphocytes. NLRC5 was sufficient to induce MHC I expression in a human lymphoid cell line, requiring both caspase recruitment and LRR domains. Moreover, endogenous NLRC5 localized to the nucleus and occupied the proximal promoter region of H-2 genes. Consistent with downregulated MHC I expression, the elimination of Nlrc5D/D lymphocytes by cytotoxic T cells was markedly reduced and, in addition, we observed low NLRC5 expression in several murine and human lymphoid-derived tumor cell lines.
    [Show full text]
  • Post-Transcriptional Inhibition of Luciferase Reporter Assays
    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 34, pp. 28705–28716, August 17, 2012 © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Post-transcriptional Inhibition of Luciferase Reporter Assays by the Nod-like Receptor Proteins NLRX1 and NLRC3* Received for publication, December 12, 2011, and in revised form, June 18, 2012 Published, JBC Papers in Press, June 20, 2012, DOI 10.1074/jbc.M111.333146 Arthur Ling‡1,2, Fraser Soares‡1,2, David O. Croitoru‡1,3, Ivan Tattoli‡§, Leticia A. M. Carneiro‡4, Michele Boniotto¶, Szilvia Benko‡5, Dana J. Philpott§, and Stephen E. Girardin‡6 From the Departments of ‡Laboratory Medicine and Pathobiology and §Immunology, University of Toronto, Toronto M6G 2T6, Canada, and the ¶Modulation of Innate Immune Response, INSERM U1012, Paris South University School of Medicine, 63, rue Gabriel Peri, 94276 Le Kremlin-Bicêtre, France Background: A number of Nod-like receptors (NLRs) have been shown to inhibit signal transduction pathways using luciferase reporter assays (LRAs). Results: Overexpression of NLRX1 and NLRC3 results in nonspecific post-transcriptional inhibition of LRAs. Conclusion: LRAs are not a reliable technique to assess the inhibitory function of NLRs. Downloaded from Significance: The inhibitory role of NLRs on specific signal transduction pathways needs to be reevaluated. Luciferase reporter assays (LRAs) are widely used to assess the Nod-like receptors (NLRs)7 represent an important class of activity of specific signal transduction pathways. Although pow- intracellular pattern recognition molecules (PRMs), which are erful, rapid and convenient, this technique can also generate implicated in the detection and response to microbe- and dan- www.jbc.org artifactual results, as revealed for instance in the case of high ger-associated molecular patterns (MAMPs and DAMPs), throughput screens of inhibitory molecules.
    [Show full text]
  • NOD-Like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
    International Journal of Molecular Sciences Review NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy Rayne R. Lim 1,2,3, Margaret E. Wieser 1, Rama R. Ganga 4, Veluchamy A. Barathi 5, Rajamani Lakshminarayanan 5 , Rajiv R. Mohan 1,2,3,6, Dean P. Hainsworth 6 and Shyam S. Chaurasia 1,2,3,* 1 Ocular Immunology and Angiogenesis Lab, University of Missouri, Columbia, MO 652011, USA; [email protected] (R.R.L.); [email protected] (M.E.W.); [email protected] (R.R.M.) 2 Department of Biomedical Sciences, University of Missouri, Columbia, MO 652011, USA 3 Ophthalmology, Harry S. Truman Memorial Veterans’ Hospital, Columbia, MO 652011, USA 4 Surgery, University of Missouri, Columbia, MO 652011, USA; [email protected] 5 Singapore Eye Research Institute, Singapore 169856, Singapore; [email protected] (V.A.B.); [email protected] (R.L.) 6 Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO 652011, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-573-882-3207 Received: 9 December 2019; Accepted: 27 January 2020; Published: 30 January 2020 Abstract: Diabetic retinopathy (DR) is an ocular complication of diabetes mellitus (DM). International Diabetic Federations (IDF) estimates up to 629 million people with DM by the year 2045 worldwide. Nearly 50% of DM patients will show evidence of diabetic-related eye problems. Therapeutic interventions for DR are limited and mostly involve surgical intervention at the late-stages of the disease. The lack of early-stage diagnostic tools and therapies, especially in DR, demands a better understanding of the biological processes involved in the etiology of disease progression.
    [Show full text]
  • Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
    University of Massachusetts Medical School eScholarship@UMMS Open Access Publications by UMMS Authors 2021-03-09 Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation Karthik Dhatchinamoorthy University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Amino Acids, Peptides, and Proteins Commons, Biological Factors Commons, Cancer Biology Commons, Hemic and Immune Systems Commons, Immunopathology Commons, Neoplasms Commons, and the Pathology Commons Repository Citation Dhatchinamoorthy K, Colbert JD, Rock KL. (2021). Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Open Access Publications by UMMS Authors. https://doi.org/10.3389/ fimmu.2021.636568. Retrieved from https://escholarship.umassmed.edu/oapubs/4636 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. REVIEW published: 09 March 2021 doi: 10.3389/fimmu.2021.636568 Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation Karthik Dhatchinamoorthy, Jeff D. Colbert and Kenneth L. Rock* Department of Pathology, UMass Medical School, Worcester, MA, United States Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell’s expressed genes and then transport and display this antigenic information on the cell surface. This allows CD8T cells to identify pathological cells that are synthesizing abnormal proteins, such as cancers that are expressing mutated proteins.
    [Show full text]
  • Expression of Specific Inflammasome Gene Modules Stratifies Older
    ARTICLES Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states David Furman1,2, Junlei Chang3, Lydia Lartigue4, Christopher R Bolen5,11, François Haddad6, Brice Gaudilliere5, Edward A Ganio5, Gabriela K Fragiadakis5, Matthew H Spitzer5, Isabelle Douchet7, Sophie Daburon7, Jean-François Moreau7, Garry P Nolan5, Patrick Blanco7, Julie Déchanet-Merville7, Cornelia L Dekker8, Vladimir Jojic9, Calvin J Kuo3, Mark M Davis1,10 & Benjamin Faustin7 Low-grade, chronic inflammation has been associated with many diseases of aging, but the mechanisms responsible for producing this inflammation remain unclear. Inflammasomes can drive chronic inflammation in the context of an infectious disease or cellular stress, and they trigger the maturation of interleukin-1b (IL-1b). Here we find that the expression of specific inflammasome gene modules stratifies older individuals into two extremes: those with constitutive expression of IL-1b, nucleotide metabolism dysfunction, elevated oxidative stress, high rates of hypertension and arterial stiffness; and those without constitutive expression of IL-1b, who lack these characteristics. Adenine and N4-acetylcytidine, nucleotide-derived metabolites that are detectable in the blood of the former group, prime and activate the NLRC4 inflammasome, induce the production of IL-1b, activate platelets and neutrophils and elevate blood pressure in mice. In individuals over 85 years of age, the elevated expression of inflammasome gene modules was associated with all-cause mortality. Thus, targeting inflammasome components may ameliorate chronic inflammation and various other age-associated conditions. Low-grade chronic inflammation has been associated with many a 5-year period in individuals who were hypertensive and who also of the diseases associated with aging1–7, but the mechanisms that exhibited other comorbidities.
    [Show full text]
  • NLRC5 Regulates Expression of MHC-I and Provides a Target for Anti-Tumor Immunity in Transmissible Cancers
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.06.274720; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 TITLE 2 NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in 3 transmissible cancers 4 RUNNING TITLE 5 NLRC5 upregulates MHC-I on transmissible tumors 6 AUTHORS 7 Chrissie E. B. Ong1*, Amanda L. Patchett1, Jocelyn M. Darby1, Jinying Chen1,2, Guei-Sheung 8 Liu1,3, A. Bruce Lyons4, Gregory M. Woods1, Andrew S. Flies1* 9 AFFILIATIONS 10 1Menzies Institute for Medical Research, College of Health and Medicine, University of 11 Tasmania, Hobart, TAS, Australia 12 2Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou, 13 China 14 3Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, 15 Australia 16 4Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, 17 Hobart, TAS, Australia 18 CORRESPONDING AUTHORS CONTACT INFORMATION 19 Andrew S. Flies, PhD 20 Menzies Institute for Medical Research, College of Health and Medicine 21 University of Tasmania 22 Private Bag 23, Hobart TAS 7000 23 phone: +61 3 6226 4614; email: [email protected] 24 Chrissie E. B. Ong, PhD candidate 25 Menzies Institute for Medical Research, College of Health and Medicine 26 University of Tasmania 27 Private Bag 23, Hobart TAS 7000 28 email: [email protected] 29 KEYWORDS 30 transmissible cancer, devil facial tumor, allograft, MHC-I, NLRC5, contagious cancer, 31 immune evasion, wild immunology 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.06.274720; this version posted September 7, 2020.
    [Show full text]
  • Structural and Evolutionary Adaptation of NOD-Like Receptors in Birds
    Hindawi BioMed Research International Volume 2021, Article ID 5546170, 11 pages https://doi.org/10.1155/2021/5546170 Research Article Structural and Evolutionary Adaptation of NOD-Like Receptors in Birds Xueting Ma ,1,2 Baohong Liu ,1,2 Zhenxing Gong ,1,2 Xinmao Yu ,1,2 and Jianping Cai 1,2 1State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Xujiaping 1, Lanzhou, Gansu Province 730046, China 2Jiangsu Co-Innovation Center for Prevention and Control of Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu Province 225009, China Correspondence should be addressed to Jianping Cai; [email protected] Received 25 February 2021; Revised 7 April 2021; Accepted 20 April 2021; Published 30 April 2021 Academic Editor: Hafiz Ishfaq Ahmad Copyright © 2021 Xueting Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. NOD-like receptors (NLRs) are intracellular sensors of the innate immune system that recognize intracellular pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). Little information exists regarding the incidence of positive selection in the evolution of NLRs of birds or the structural differences between bird and mammal NLRs. Evidence of positive selection was identified in four avian NLRs (NOD1, NLRC3, NLRC5, and NLRP3) using the maximum likelihood approach. These NLRs are under different selection pressures which is indicative of different evolution patterns. Analysis of these NLRs showed a lower percentage of codons under positive selection in the LRR domain than seen in the studies of Toll- like receptors (TLRs), suggesting that the LRR domain evolves differently between NLRs and TLRs.
    [Show full text]
  • Cellular Immunology 341 (2019) 103920
    Cellular Immunology 341 (2019) 103920 Contents lists available at ScienceDirect Cellular Immunology journal homepage: www.elsevier.com/locate/ycimm Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis T Gaurav Guptaa,d,1, Alynne K.M. Santanaa,1, Ciro M. Gomesb, Aline Turattic, Cristiane M. Milanezia, Roberto Bueno Filhoc, Carlos Fuzoa, Roque P. Almeidae, ⁎ Vanessa Carregaroa, Ana M. Roselinoc, João S. Silvaa,f, a Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil b Division of Dermatology, Department of Medical Clinics, Faculty of Medicine, University of Brasília, Brasília, Brazil c Division of Dermatology, Department of Medical Clinics, Faculty of Medicine, University of São Paulo, São Paulo, Brazil d Department of Immunology, University of Manitoba, Winnipeg, Canada e Department of Medicine, Federal University of Sergipe, Aracaju, Brazil f Bi-Institutional Translational Medicine Project, Fundação Oswaldo Cruz, Fiocruz, Brazil ARTICLE INFO ABSTRACT Keywords: Localized cutaneous leishmaniasis (LCL) can ultimately progress to chronic ulcerated lesions with strong local Human localized cutaneous leishmaniasis inflammatory reactions. The functional role of certain inflammasomes in mediating inflammation caused by Inflammasomes Leishmania braziliensis needs to be addressed. By combining PCR-array, quantitative real-time PCR and im- AIM2 munohistochemical analysis, we identified inflammasome genes, such as IL-1β, NLRP3, NLRP1, NLRC5, AIM2 NLRP3 and P2RX7, that were upregulated in LCL patients. Temporal gene expression studies showed that the early IL-1β phase of LCL displayed increased NLRP3 and reduced AIM2 and NLRP1 expression, while the late stages showed Inflammation increased AIM2 and NLRP1 and lower NLRP3 expression. Our findings also showed that AIM2, NLRP1, and P2RX7 promoted susceptibility to experimental L.
    [Show full text]
  • NOD-Like Receptors (Nlrs) and Inflammasomes
    International Edition www.adipogen.com NOD-like Receptors (NLRs) and Inflammasomes In mammals, germ-line encoded pattern recognition receptors (PRRs) detect the presence of pathogens through recognition of pathogen-associated molecular patterns (PAMPs) or endogenous danger signals through the sensing of danger-associated molecular patterns (DAMPs). The innate immune system comprises several classes of PRRs that allow the early detection of pathogens at the site of infection. The membrane-bound toll-like receptors (TLRs) and C-type lectin receptors (CTRs) detect PAMPs in extracellular milieu and endo- somal compartments. TRLs and CTRs cooperate with PRRs sensing the presence of cytosolic nucleic acids, like RNA-sensing RIG-I (retinoic acid-inducible gene I)-like receptors (RLRs; RLHs) or DNA-sensing AIM2, among others. Another set of intracellular sensing PRRs are the NOD-like receptors (NLRs; nucleotide-binding domain leucine-rich repeat containing receptors), which not only recognize PAMPs but also DAMPs. PAMPs FUNGI/PROTOZOA BACTERIA VIRUSES MOLECULES C. albicans A. hydrophila Adenovirus Bacillus anthracis lethal Plasmodium B. brevis Encephalomyo- toxin (LeTx) S. cerevisiae E. coli carditis virus Bacterial pore-forming L. monocytogenes Herpes simplex virus toxins L. pneumophila Influenza virus Cytosolic dsDNA N. gonorrhoeae Sendai virus P. aeruginosa Cytosolic flagellin S. aureus MDP S. flexneri meso-DAP S. hygroscopicus S. typhimurium DAMPs MOLECULES PARTICLES OTHERS DNA Uric acid UVB Extracellular ATP CPPD Mutations R837 Asbestos Cytosolic dsDNA Irritants Silica Glucose Alum Hyaluronan Amyloid-b Hemozoin Nanoparticles FIGURE 1: Overview on PAMPs and DAMPs recognized by NLRs. NOD-like Receptors [NLRs] The intracellular NLRs organize signaling complexes such as inflammasomes and NOD signalosomes.
    [Show full text]
  • NLRP10 Enhances Shigellainduced Proinflammatory Responses
    Cellular Microbiology (2012) doi:10.1111/j.1462-5822.2012.01822.x NLRP10 enhances Shigella-induced pro-inflammatory responses Katja Lautz,1 Anna Damm,1 Maureen Menning,1 Introduction Julia Wenger,2 Alexander C. Adam,3 Paola Zigrino,4 Elisabeth Kremmer5 and Thomas A. Kufer1* The innate immune system is the first line of defence 1Institute for Medical Microbiology, Immunology and against invading pathogens in mammals. By gaining Hygiene, University of Cologne, Cologne, Germany. access to the cellular cytoplasm, some bacteria and 2Department of Molecular Biology, University of viruses adopted to escape host innate immune surveil- Salzburg, Salzburg, Austria. lance by membrane standing pattern-recognition recep- 3Department of Pathology, University of Cologne, tors (PRRs) such as the Toll-like receptor family. To cope Cologne, Germany. with such intracellular residing pathogens, the host has 4Department of Dermatology, University of Cologne, evolved sophisticated detection systems. In particular Cologne, Germany. members of the nucleotide-binding domain leucine-rich 5Helmholtz Zentrum München, Institute of Molecular repeat containing family (NLR) have been shown to sense Immunology, Munich, Germany. such invasive bacteria and viruses. NLRs are a heteroge- neous class of 23 AAA+ ATPases in humans, which are characterized by a tripartite structural organization com- Summary prising an effector domain, a STAND type ATPase domain Members of the NLR family evolved as intracellular (called NACHT domain) and a series of leucine-rich sensors for bacterial and viral infection. However, repeats (LRRs) at the carboxyl-terminus (Fritz et al., our knowledge on the implication of most of the 2006; Schroder and Tschopp, 2010). NLRs are classified human NLR proteins in innate immune responses based on the nature of their amino-terminal effector still remains fragmentary.
    [Show full text]
  • ´The NOD-Like Receptor NLRC5 Is Involved in Interferon - Dependent Antiviral Immune Responses´
    Kuenzel et al. Supplementary information 1 Supplementary information ´The NOD-like receptor NLRC5 is involved in Interferon - dependent antiviral immune responses´ (initially entitled ´The NOD-like receptor NLRC5 is regulated by viral infection through IFN-γ dependent signaling´) Supplemental Figure Legends. S1. The gene tree was created using the TreeBeST method (http://treesoft.sourceforge.net/treebest.shtml) and annotates the evolutionary origin of NLRC5 within the NLR family. The internal nodes are colour-coded to discriminate duplication or speciation events. Red-squared nodes represent gene duplications events, blue-squared nodes represent speciation events. The data suggest that the gene emerged from a duplication ancestor node early in mammalian evolution. S2. Schematic representation of the NLRC5-specific constructs used in this study. S3. Subcellular localisation of NLRC5. GFP-NLRC5 fusion protein was overexpressed in HeLaS3 cells, and cells were fixed using 4% PFA followed by staining with LysoTracker. GFP-NLRC5 is localized in the cytosol exhibiting a spot-like expression pattern and does not co-localize with lysosomes or mitochondria (not shown). DAPI was used to stain nucleic DNA. S4. Different human cell lines were assayed for NLRC5 mRNA expression levels using TaqMan real-time PCR after stimulation with different cytokines, pathogen –associated molecular patterns (PAMPs) or living bacteria (Listeria monocytogenes): EGF (100ng/ml), TNF-α (10ng/ml), LPS (10µg/ml), Flagellin (500ng/ml), IFN-γ (1000u/ml) or infected with Listeria monocytogenes (multiplicity of infection = 100 bacteria/cell). Kuenzel et al. Supplementary information 2 Expression levels of NLRC5 were normalized to expression of housekeeping gene β- Actin. Only stimulation with IFN-γ resulted in significant upregulation of NLRC5 mRNA expression.
    [Show full text]